Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tretinoin for Axillary Hyperpigmentation in Acanthosis Nigricans
NCT06213987Phase 3Completed
- Sponsor
- Srinakharinwirot University
- Start
- Feb 2024
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in acanthosis nigricans comparing Tretinoin Side with Placebo Side (2 arms). Primary endpoint: Melanin index assessed by Mexameter at 8 weeks. Started Feb 2024; status: completed.
02
Drugs
tretinoin
03
Conditions
acanthosis nigricans
Beyond the preview
Go deeper on NCT06213987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06213987.